Skip to Content

4833M 15/850 (Actoplus Met 850 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill with imprint 4833M 15/850 is White, Elliptical / Oval and has been identified as Actoplus Met 850 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4833M 15/850

Actoplus met 850 mg / 15 mg 4833M 15/850
Actoplus met 850 mg / 15 mg 4833M 15/850 Front
Actoplus met 850 mg / 15 mg 4833M 15/850 Back
Actoplus met 850 mg / 15 mg 4833M 15/850

Actoplus Met

Generic Name:
metformin/pioglitazone
Imprint:
4833M 15/850
Strength:
850 mg / 15 mg
Color:
White
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
Inactive Ingredients:
povidone
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
hypromellose 2910 (6 mPa.s)
polyethylene glycol 8000
titanium dioxide
magnesium silicate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00093-5050 Teva Pharmaceuticals USA, Inc.
42291-0694 AvKare, Inc.
54868-5553 Physicians Total Care Inc. (repackager)
35356-0130 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide